Evidence map›Paper›PMID 33793318›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Reply to K. Ando et al.

Joseph A Sparano, Michael R Crager, Gong Tang, Robert J Gray, Salomon M Stemmer, Steven Shak

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Joseph A SparanoJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.ORCID 0000-0002-9031-2010
Michael R CragerJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.ORCID 0000-0002-3594-6299
Gong TangJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.ORCID 0000-0002-6247-4338
Robert J GrayJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.ORCID 0000-0002-5724-4917
Salomon M StemmerJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.
Steven ShakJoseph A. Sparano, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Michael R. Crager, PhD, Exact Sciences, Redwood City, CA; Gong Tang, PhD, University of Pittsburgh, NRG Oncology Statistical and Data Management Center, Pittsburgh, PA; Robert J. Gray, PhD, Dana Farber Cancer Institute, ECOG-ACRIN Statistical Center, Boston, MA; Salomon M. Stemmer, MD, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Steven Shak, MD, Exact Sciences, Redwood City, CA.

Funding

Montefiore Academic Community NCORP ProgramUG1CA189859 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI Balazs Halmos, Della Makower · 2014 to 2026
$10.8M
NCI NIH HHS UG1 CA189859
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33793318
PMCPMC8260921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.